Status:
COMPLETED
Effects of Acupuncture as Adjunctive Therapy in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Universiti Putra Malaysia
Conditions:
Diabetes Mellitus, Type 2
Acupuncture
Eligibility:
All Genders
30-69 years
Phase:
NA
Brief Summary
This study aims to determine the effect of acupuncture as an adjunctive therapy on homeostasis model assessment-insulin resistance (HOMA-IR) and health-related quality of life (HRQoL) in patients with...
Detailed Description
This is a randomised, double-blind, placebo controlled and parallel design trial. Participants will be randomized to either acupuncture (n=30) or placebo (n=30) using a 1:1 ratio. The permuted blocks ...
Eligibility Criteria
Inclusion
- Fasting plasma glucose (FPG) ≥ 7.0 mmol/L \[126 mg/dL\] or HbA1c ≥ 6.5%.
- Subjects have had type 2 diabetes mellitus for more than one year
- Receive oral anti-diabetic agents on a stable dose over the previous 3 months.
Exclusion
- Under insulin therapy
- With other acute or chronic health problems
- Body mass index (BMI) ≥ 40.0 kg/m²
- Needle phobia or allergy to adhesive plaster
- Planning to move out from Malaysia within 4 months'
- Being pregnant, planning for pregnancy or lactating women
Key Trial Info
Start Date :
May 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04829045
Start Date
May 27 2021
End Date
December 31 2022
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universiti Putra Malaysia
Serdang, Selangor, Malaysia, 43400